Clarivate (NYSE: CLVT) officer sells 309,902 shares in Rule 10b5-1 trade

Rhea-AI Filing Summary

Clarivate plc executive share sale reported

A Clarivate plc officer, listed as President, A&G, reported selling 309,902 ordinary shares of CLVT on December 1, 2025. The transaction was coded as a sale and executed under a pre-arranged Rule 10b5-1 trading plan adopted on August 5, 2025. The weighted average sale price was $3.74 per share, with individual sale prices ranging from $3.71 to $3.78.

After this transaction, the reporting person directly beneficially owns 848,811 ordinary shares of Clarivate. The filer notes they can provide details on the number of shares sold at each price within the stated range upon request.

Insider Trade Summary

Net Seller: 309,902 shares ($1,159,033)

Net Sell 1 txn

Insider Veinstein Bar

Role President, A&G

Sold 309,902 shs ($1.16M)

Type	Security	Shares	Price	Value
Sale	Ordinary Shares	309,902	$3.74	$1.16M

Holdings After Transaction: Ordinary Shares — 848,811 shares (Direct)

Footnotes (1)

1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 5, 2025. The price reported is a weighted average price. The prices ranged from $3.71 to $3.78, inclusive. The Reporting Person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Veinstein Bar

(Last) (First) (Middle)

C/O CLARIVATE PLC

70 ST MARY AXE

(Street)

LONDON X0 EC3A 8BE

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CLARIVATE PLC [ CLVT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, A&G

3. Date of Earliest Transaction (Month/Day/Year)
12/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	12/01/2025		S(1)		309,902	D	$3.74(2)	848,811	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 5, 2025.

2. The price reported is a weighted average price. The prices ranged from $3.71 to $3.78, inclusive. The Reporting Person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Remarks:

	/s/ John Doulamis, Attorney-in-Fact	12/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Clarivate (CLVT) report in this Form 4?

A Clarivate plc officer reported selling 309,902 ordinary shares of CLVT on December 1, 2025, as disclosed in a Form 4 filing.

At what price were the Clarivate (CLVT) shares sold in the reported transaction?

The sale used a weighted average price of $3.74 per share, with individual trades executed between $3.71 and $3.78, inclusive.

How many Clarivate (CLVT) shares does the insider own after the sale?

Following the reported sale, the Clarivate officer directly beneficially owns 848,811 ordinary shares of CLVT.

Was the Clarivate (CLVT) insider sale made under a Rule 10b5-1 plan?

Yes. The filing states the sales were effected under a Rule 10b5-1 trading plan adopted by the reporting person on August 5, 2025.

What is the reporting person’s role at Clarivate (CLVT)?

The reporting person is identified as an officer of Clarivate plc with the title President, A&G.

Can investors see the exact prices for each Clarivate (CLVT) trade in this Form 4?

The filing notes that the reporting person will provide, upon request, information on the number of shares sold at each price within the $3.71–$3.78 range.